2796 — Pharmarise Holdings Share Price
0.000.00%
Last trade - 00:00- ¥5bn
- ¥18bn
- ¥54bn
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 0.79 | ||
| Price to Tang. Book | n/a | ||
| Price to Free Cashflow | 67.88 | ||
| Price to Sales | 0.09 | ||
| EV to EBITDA | 35.68 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -2.48% | ||
| Return on Equity | -10.48% | ||
| Operating Margin | -0.85% | ||
Financial Summary
| Year End 31st May | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | ¥m | 51,030 | 52,324 | 51,608 | 52,030 | 54,466 | n/a | n/a | 1.04% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | +50.88 | -0.89 | -5.76 | -6.12 | -35.17 | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Pharmarise Holdings Corporation is a Japan-based holding company primarily engaged in the dispensing pharmacy businesses. Along with its subsidiaries and associated companies, the Company operates in five business segments. The Dispensing Pharmacy segment is engaged in the operation of dispensing pharmacies, which prescribe medicines to general patients based on prescriptions issued by medical institutions. The Merchandising segment consists of the cosmetics sales business, the convenience store management business and the drug store management business. The Medical Document Storage and Management segment is engaged in the storage and management of paper medical records and X-ray films. The Medical Mall Management segment is a business related to medical malls operated at JR Tower Office Plaza Sapporo in JR Sapporo Station. Others segment includes temporary staffing business and sales of stationery.
Directors
- Toshimichi Ohno CHM (68)
- Masayuki Akiyama PRE (51)
- Keiko Matsuura SMD (61)
- Sayoko Ohno MDR (67)
- Masahito Akamatsu EXO (60)
- Yutaka Numata EXO (55)
- Mitsugu Takahashi EXO (56)
- Hiroshi Kanno EXO (44)
- Motohiro Kimijima EXO
- Masanori Maruta EXO
- Katsuya Nunome EXO
- Minoru Sato EXO
- Nobuo Taguchi EXO
- Yoshihiro Tanaka EXO
- Hiroshi Terakawa EXO
- Tetsuo Onaka IND (85)
- Hiroshi Tada IND (81)
- Norio Watanabe IND
- Last Annual
- May 31st, 2024
- Last Interim
- February 28th, 2025
- Incorporated
- June 28th, 1984
- Public Since
- February 1st, 2007
- No. of Shareholders
- 13,913
- No. of Employees
- 1,848
- Sector
- Food & Drug Retailing
- Industry
- Consumer Defensives
- Exchange
- Tokyo Stock Exchange
- Shares in Issue
- 11,360,905
- Address
- 1-38-1, Chuo, NAKANO-KU, 164-0011
- Web
- https://www.pharmarise.com/
- Phone
- +81 333627130
- Auditors
- Grant Thornton Taiyo LLC
Upcoming Events for 2796
Full Year 2025 Pharmarise Holdings Corp Earnings Release
Pharmarise Holdings Corp Annual Shareholders Meeting
Q1 2026 Pharmarise Holdings Corp Earnings Release
Similar to 2796
Aeon Co
Tokyo Stock Exchange
Ain Holdings
Tokyo Stock Exchange
Albis Co
Tokyo Stock Exchange
ALPICO HOLDINGS CO
Tokyo Stock Exchange
Arcs Co
Tokyo Stock Exchange
FAQ
What is the Pharmarise Holdings share price?
As of Today at 22:38 UTC, shares in Pharmarise Holdings are trading at ¥484. This share price information is delayed by 15 minutes.
How has the Pharmarise Holdings share price performed this year?
Shares in Pharmarise Holdings last closed at ¥484 and the price had moved by -26.22% over the past 365 days. In terms of relative price strength the Pharmarise Holdings share price has underperformed the Nikkei 225 Index by -22.25% over the past year.
What are the analyst and broker recommendations for Pharmarise Holdings?
There is no consensus recommendation for this security.
Find out moreWhat is the Pharmarise Holdings dividend yield?
The Pharmarise Holdings dividend yield is 2.89% based on the trailing twelve month period.
Does Pharmarise Holdings pay a dividend?
Last year, Pharmarise Holdings paid a total dividend of ¥14, and it currently has a trailing dividend yield of 2.89%.Looking ahead, shares in Pharmarise Holdings are due to go ex-dividend on 2025-05-29 and the next dividend pay date is 2025-08-01.
When does Pharmarise Holdings next pay dividends?
Pharmarise Holdings are due to go ex-dividend on 2025-05-29 and the next dividend pay date is 2025-08-01. The historic dividend yield on Pharmarise Holdings shares is currently 2.89%.
How do I buy Pharmarise Holdings shares?
To buy shares in Pharmarise Holdings you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Pharmarise Holdings?
As of the previous close price of ¥484, shares in Pharmarise Holdings had a market capitalisation of ¥5bn.
Where are Pharmarise Holdings shares listed?
Here are the trading details for Pharmarise Holdings:
- Country of listing: Japan
- Exchange: TYO
- Ticker Symbol: 2796
What kind of share is Pharmarise Holdings?
Based on an overall assessment of its quality, value and momentum Pharmarise Holdings is currently classified as a Sucker Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Pharmarise Holdings share price forecast for 2025?
We could not find analyst target price data for this security.
Find out moreWhat is the trend in the Pharmarise Holdings share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Pharmarise Holdings. Over the past six months, its share price has underperformed the Nikkei 225 Index by -16.54%.
As of the last closing price of ¥484, shares in Pharmarise Holdings were trading -14.16% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Pharmarise Holdings PE Ratio?
The Pharmarise Holdings PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at ¥484.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Pharmarise Holdings?
Pharmarise Holdings' management team is headed by:
- Toshimichi Ohno - CHM
- Masayuki Akiyama - PRE
- Keiko Matsuura - SMD
- Sayoko Ohno - MDR
- Masahito Akamatsu - EXO
- Yutaka Numata - EXO
- Mitsugu Takahashi - EXO
- Hiroshi Kanno - EXO
- Motohiro Kimijima - EXO
- Masanori Maruta - EXO
- Katsuya Nunome - EXO
- Minoru Sato - EXO
- Nobuo Taguchi - EXO
- Yoshihiro Tanaka - EXO
- Hiroshi Terakawa - EXO
- Tetsuo Onaka - IND
- Hiroshi Tada - IND
- Norio Watanabe - IND